Report cover image

Diabetes Treatment Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Jan 01, 2025
Length 130 Pages
SKU # FOB19554812

Description

Growth Factors of Diabetes Treatment Devices Market

The global diabetes treatment devices market size was valued at USD 10.83 billion in 2018 and is projected tgrow tUSD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period of 2019-2032.

The COVID-19 pandemic disrupted shipping chains and healthcare entry, affecting the Diabetes Treatment Devices Market. However, it expanded the call for domestic-use devices like insulin pumps and non-stop glucose videshow gadgets, driven by the desire for extended growthway-flung healthcare and self-control tools, impeding the diabetes treatment devices market.

The Diabetes Treatment Devices Market is pushed via the rising occurrence of diabetes, technological advancements in insulin shipping systems, the growing adoption of wearable gadgets for diabetes control, and growing interest in self-management systems. Supportive authorities' projects and transfers towards domestic healthcare have alscontributed tthe market boom.

The Diabetes Treatment Devices Market is experiencing an enormous boom, driven by the rising occurrence of diabetes globally and the growing demand for stepped-forward glycemic control. Key traits encompass developing sophisticated non-prevent glucose tracking (CGM) structures with extra accuracy and capabilities like actual-time indicators, predictive analytics, and expanding diabetes treatment devices market share globally. Additionally, improvements in insulin shipping systems, computerized insulin delivery systems (AID), and wearable insulin pumps allow greater customized and powerful diabetes management.

Comprehensive Analysis of Diabetes Treatment Devices Market

The Diabetes Treatment Devices Market is segmented intmerchandise and distribution channels. By product, the market includes insulin pens, insulin pumps, insulin jet injectors, insulin syringes, and others. The insulin pens segment is predicted texpand swiftly because of their comfort and minimum invasiveness compared tconventional insulin syringes. Insulin pumps, which constantly infuse insulin, are alsexpected tenjoy a giant growth due tthe more and more widespread type one diabetes patients. The distribution channel cuts the marketplace intretail and institutional earnings. Retail sales are anticipated tdominate because of the growing availability of personal-label producers and partnerships between marketplace players tincrease earnings globally. Meanwhile, institutional income is pushed through the call for blood glucose monitors in hospitals, mainly for non-diabetic sufferers.

The Asia Pacific region led the diabetes treatment devices market by benefitting a size of USD 4.38 billion in 2018 due tthe adoption of technologically advanced insulin shipping devices and the elevated call for for minimally invasive insulin delivery gadgets.

The leading players in the diabetes treatment devices market significantly influence its growth trajectory and set industry standards. These key players, including F. Hoffmann-La Roche Ltd (Switzerland), Tandem Diabetes Care, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic (Ireland), BD (U.S.), NovNordisk A/S (Denmark), Abbott (U.S.), and Sanofi (France), contribute ta competitive landscape, driving innovation and advancements in diabetes care technologies. These companies continue tshape the market with cutting-edge solutions, expanding access tadvanced insulin delivery devices and other treatment solutions.

In April 2021, BIOCORP and Roche Diabetes Care, France, revealed the advent of Mallya, a clever insulin injection pen. This partnership will enable BIOCORP tutilize Roche's substantial distribution network in pharmacies.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2015-2026

Base Year 2018

Forecast Period 2019-2026

Historical Period 2015-2017

Unit Value (USD billion)

Segmentation By Product

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

Insulin Syringes

Others

By Distribution Channel

Institutional Sales

Hospitals

Clinics

Others

Retail Sales

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Geography

North America (U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Contents

130 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence and Incidence of Diabetes by Key Countries
4.2. Advancements in Insulin Delivery Devices
4.3. Pricing Analysis, By Key Countries/ Key Regions
4.4. Recent Industry Developments Such As Mergers & Acquisitions
5. Global Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1. Insulin Pens
5.2.2. Insulin Pumps
5.2.3. Insulin Jet Injectors
5.2.4. Insulin Syringes
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1. Institutional Sales
5.3.1.1. Hospitals
5.3.1.2. Clinics
5.3.1.3. Others
5.3.2. Retail Sales
5.3.2.1. Online Pharmacies
5.3.2.2. Hospital Pharmacies
5.3.2.3. Retail Pharmacies
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1. Insulin Pens
6.2.2. Insulin Pumps
6.2.3. Insulin Jet Injectors
6.2.4. Insulin Syringes
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1. Institutional Sales
6.3.1.1. Hospitals
6.3.1.2. Clinics
6.3.1.3. Others
6.3.2. Retail Sales
6.3.2.1. Online Pharmacies
6.3.2.2. Hospital Pharmacies
6.3.2.3. Retail Pharmacies
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Product
7.2.1. Insulin Pens
7.2.2. Insulin Pumps
7.2.3. Insulin Jet Injectors
7.2.4. Insulin Syringes
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1. Institutional Sales
7.3.1.1. Hospitals
7.3.1.2. Clinics
7.3.1.3. Others
7.3.2. Retail Sales
7.3.2.1. Online Pharmacies
7.3.2.2. Hospital Pharmacies
7.3.2.3. Retail Pharmacies
7.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
7.4.1. U.K.
7.4.2. Spain
7.4.3. Italy
7.4.4. Germany
7.4.5. France
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Product
8.2.1. Insulin Pens
8.2.2. Insulin Pumps
8.2.3. Insulin Jet Injectors
8.2.4. Insulin Syringes
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Distribution Channel
8.3.1. Institutional Sales
8.3.1.1. Hospitals
8.3.1.2. Clinics
8.3.1.3. Others
8.3.2. Retail Sales
8.3.2.1. Online Pharmacies
8.3.2.2. Hospital Pharmacies
8.3.2.3. Retail Pharmacies
8.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
8.4.1. China
8.4.2. India
8.4.3. Australia
8.4.4. Japan
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Product
9.2.1. Insulin Pens
9.2.2. Insulin Pumps
9.2.3. Insulin Jet Injectors
9.2.4. Insulin Syringes
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Distribution Channel
9.3.1. Institutional Sales
9.3.1.1. Hospitals
9.3.1.2. Clinics
9.3.1.3. Others
9.3.2. Retail Sales
9.3.2.1. Online Pharmacies
9.3.2.2. Hospital Pharmacies
9.3.2.3. Retail Pharmacies
9.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Diabetes Treatment Devices Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Product
10.2.1. Insulin Pens
10.2.2. Insulin Pumps
10.2.3. Insulin Jet Injectors
10.2.4. Insulin Syringes
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Distribution Channel
10.3.1. Institutional Sales
10.3.1.1. Hospitals
10.3.1.2. Clinics
10.3.1.3. Others
10.3.2. Retail Sales
10.3.2.1. Online Pharmacies
10.3.2.2. Hospital Pharmacies
10.3.2.3. Retail Pharmacies
10.4. Market Analysis, Insights and Forecast – By Country/ Sub- region
10.4.1. South Africa
10.4.2. GCC
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles
11.5.1. F. Hoffmann-La Roche Ltd
11.5.1.1. Overview,
11.5.1.2. Products & services,
11.5.1.3. SWOT analysis,
11.5.1.4. Recent developments,
11.5.1.5. strategies,
11.5.1.6. financials (based on availability)
11.5.2. Tandem Diabetes Care, Inc.
11.5.2.1. Overview,
11.5.2.2. Products & services,
11.5.2.3. SWOT analysis,
11.5.2.4. Recent developments,
11.5.2.5. strategies,
11.5.2.6. financials (based on availability)
11.5.3. B. Braun Melsungen AG
11.5.3.1. Overview,
11.5.3.2. Products & services,
11.5.3.3. SWOT analysis,
11.5.3.4. Recent developments,
11.5.3.5. strategies,
11.5.3.6. financials (based on availability)
11.5.4. PHC Holdings Corporation
11.5.4.1. Overview,
11.5.4.2. Products & services,
11.5.4.3. SWOT analysis,
11.5.4.4. Recent developments,
11.5.4.5. strategies,
11.5.4.6. financials (based on availability)
11.5.5. Medtronic
11.5.5.1. Overview,
11.5.5.2. Products & services,
11.5.5.3. SWOT analysis,
11.5.5.4. Recent developments,
11.5.5.5. strategies,
11.5.5.6. financials (based on availability)
11.5.6. BD
11.5.6.1. Overview,
11.5.6.2. Products & services,
11.5.6.3. SWOT analysis,
11.5.6.4. Recent developments,
11.5.6.5. strategies,
11.5.6.6. financials (based on availability)
11.5.7. Novo Nordisk A/S
11.5.7.1. Overview,
11.5.7.2. Products & services,
11.5.7.3. SWOT analysis,
11.5.7.4. Recent developments,
11.5.7.5. strategies,
11.5.7.6. financials (based on availability)
11.5.8. Abbott
11.5.8.1. Overview,
11.5.8.2. Products & services,
11.5.8.3. SWOT analysis,
11.5.8.4. Recent developments,
11.5.8.5. strategies,
11.5.8.6. financials (based on availability)
11.5.9. Other Prominent Players
11.5.9.1. Overview,
11.5.9.2. Products & services,
11.5.9.3. SWOT analysis,
11.5.9.4. Recent developments,
11.5.9.5. strategies,
11.5.9.6. financials (based on availability)
12. Strategic Recommendations
"

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us